enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Meglitinide - Wikipedia

    en.wikipedia.org/wiki/Meglitinide

    Repaglinide (trade name Prandin) [2] gained US Food and Drug Administration approval in 1997. Other drugs in this class include nateglinide (Starlix) [ 3 ] and mitiglinide (Glufast). Side effects

  3. Repaglinide - Wikipedia

    en.wikipedia.org/wiki/Repaglinide

    Repaglinide is a major substrate of CYP3A4 and should not be administered concomitantly with gemfibrozil, clarithromycin or azole antifungals such as itraconazole or ketoconazole. [1] Administration of both repaglinide and one or more of these drugs results in an increase in plasma concentration of repaglinide and may lead to hypoglycemia.

  4. Glimepiride - Wikipedia

    en.wikipedia.org/wiki/Glimepiride

    Glimepiride is an antidiabetic medication within the sulfonylurea class, primarily prescribed for the management of type 2 diabetes. [ 1 ] [ 2 ] It is regarded as a second-line option compared to metformin , due to metformin's well-established safety and efficacy. [ 1 ]

  5. FDA approves new type of non-opioid pain medication, 1st of ...

    www.aol.com/fda-approves-type-non-opioid...

    The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to treat moderate to severe acute pain. The drug, called Journavx ...

  6. Nateglinide - Wikipedia

    en.wikipedia.org/wiki/Nateglinide

    A study funded by Novo Nordisk, the U.S. distributor for Repaglinide, compared their product with Nateglinide in "A randomized, parallel-group, open-label, multicenter 16-week clinical trial". [1] They concluded that the two were similar, but "repaglinide monotherapy was significantly more effective than nateglinide monotherapy in reducing ...

  7. Dipeptidyl peptidase-4 inhibitor - Wikipedia

    en.wikipedia.org/wiki/Dipeptidyl_peptidase-4...

    DPP-4 inhibitors and GLP-1. Inhibitors of dipeptidyl peptidase 4 (DPP-4 inhibitors or gliptins) are a class of oral hypoglycemics that block the enzyme dipeptidyl peptidase-4 (DPP-4). They can be used to treat diabetes mellitus type 2. The first agent of the class – sitagliptin – was approved by the FDA in 2006. [1]

  8. What Happens If I Stop Taking GLP-1s for Weight Loss? - AOL

    www.aol.com/happens-stop-taking-glp-1s-145700921...

    Focus on Healthy Habits. Lifestyle changes are key to maintaining your progress. While semaglutide may have helped you along the way, sustainable habits will carry you forward.

  9. Trump to call for 'all of government' response to fight ... - AOL

    www.aol.com/news/trump-call-government-response...

    President-elect Donald Trump on Monday will sign a memorandum aimed at fighting inflation after he takes office that calls for an "all of government" response to bring down costs for Americans, an ...